What the company does
Akeso, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer, lung cancer, and liver cancer; and AK112, a PD-1/VEGF bi-specific antibody to treat lung cancer, biliary tract cancer, head and neck squamous cell carcinoma, breast cancer, colorectal cancer, and pancreatic cancer. It is also developing AK117, a CD47 monoclonal antibody to treat myelodysplastic syndrome, acute myeloid leukemia, and recurrent or refractory classical Hodgkin lymphoma; AK109, a PD-1 monoclonal antibody to treat G/GEJ patients; penpulimab, …
What the weekly tape is saying
9926 closed the latest completed week at 92.00 HKD. The 4-week return is -23.5% and the 12-week return is -20.4%. Trend Signal is inactive, Market Dynamics is -0.27. Setup signature: Risk-first tape with a 23/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 118.3 HKD
- Vs Trend Line
- -22.3%
- Fair Value
- 77.13 HKD
- Vs Fair Value
- 19.3%
- 52W High
- 179.0 HKD
- 52W Low
- 82.85 HKD
- Drawdown
- -48.6%
- Range Position
- 9.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 27
- 52W Active Breadth
- 51.9%
- Sector Scope
- HK Healthcare
- Sector Rank
- 134 of 257
- Sector Percentile
- 48.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 86 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 54 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.27
- 4W MD Change
- -133.3%
- Relative Strength
- -23.18
- 4W RS Change
- -537.6%
- Expectation
- Positive
- Probability
- 62.15%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 95.0M
- 13W Average
- 52.8M
- 52W Average
- 46.2M
- Vs 13W
- 1.8x
- Vs 52W
- 2.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.9%
- 52W Volatility
- 8.4%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 6.5% / -5.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 106.8B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 92.00 HKD | -1.7% | 118.3 HKD | 77.13 HKD | -0.27 | -23.18 | 95.0M | Off |
| 5 Jun 2026 | 93.60 HKD | -20.7% | 119.2 HKD | 76.78 HKD | -0.01 | -22.70 | 157.5M | Off |
| 29 May 2026 | 118.1 HKD | 1.3% | 119.9 HKD | 76.41 HKD | 0.33 | -3.21 | 38.8M | On |
| 22 May 2026 | 116.6 HKD | -3.0% | 119.7 HKD | 75.88 HKD | 0.54 | -5.61 | 39.8M | On |
| 15 May 2026 | 120.2 HKD | -10.3% | 119.7 HKD | 75.37 HKD | 0.81 | -3.64 | 31.4M | On |
| 8 May 2026 | 134.0 HKD | -1.3% | 119.7 HKD | 74.84 HKD | 1.12 | 6.12 | 39.7M | On |
| 1 May 2026 | 135.8 HKD | 3.2% | 119.5 HKD | 74.26 HKD | 1.16 | 10.74 | 25.4M | On |
| 24 Apr 2026 | 131.6 HKD | -12.8% | 119.7 HKD | 73.67 HKD | 1.37 | 7.07 | 60.7M | On |
| 17 Apr 2026 | 151.0 HKD | 9.3% | 119.7 HKD | 73.11 HKD | 1.38 | 22.28 | 40.0M | On |
| 10 Apr 2026 | 138.2 HKD | -1.6% | 119.0 HKD | 72.41 HKD | 0.99 | 13.95 | 22.5M | Off |
| 3 Apr 2026 | 140.5 HKD | 11.2% | 118.9 HKD | 71.83 HKD | 0.64 | 20.12 | 47.5M | Off |
| 27 Mar 2026 | 126.4 HKD | 9.3% | 119.4 HKD | 71.21 HKD | 0.13 | 9.61 | 50.9M | Off |
| 20 Mar 2026 | 115.6 HKD | 4.9% | 120.4 HKD | 70.66 HKD | -0.30 | -0.26 | 36.8M | Off |
| 13 Mar 2026 | 110.2 HKD | 2.7% | 122.4 HKD | 70.18 HKD | -0.47 | -4.94 | 44.0M | Off |